Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 19, Issue 2, Pages -
Publisher
Informa UK Limited
Online
2023-11-07
DOI
10.1080/21645515.2023.2264594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge
- (2023) Dan Bi Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever
- (2023) Anna Lacasta et al. Frontiers in Immunology
- Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study
- (2023) Ronen Arbel et al. LANCET INFECTIOUS DISEASES
- Tracking the COVID-19 vaccines: The global landscape
- (2023) Tushar Yadav et al. Human Vaccines & Immunotherapeutics
- Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
- (2023) Sakshi Bajoria et al. Vaccines
- The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus
- (2023) Gabriela Brzuska et al. Microbiology Spectrum
- An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
- (2022) Etsuro Nanishi et al. Science Translational Medicine
- Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
- (2022) Jeroen Pollet et al. VACCINE
- SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
- (2022) Neil C. Dalvie et al. Science Advances
- Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
- (2022) Lilit Grigoryan et al. npj Vaccines
- Analytical and preformulation characterization studies of human papillomavirus virus-like particles to enable quadrivalent multi-dose vaccine formulation development
- (2022) Kaushal Jerajani et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
- (2022) Alexander A. Cohen et al. SCIENCE
- Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
- (2022) Sakshi Bajoria et al. Human Vaccines & Immunotherapeutics
- Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations
- (2022) Kaushal Jerajani et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
- (2022) Nitya Sharma et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
- (2022) Prashant Kumar et al. Human Vaccines & Immunotherapeutics
- A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
- (2021) Tiong Kit Tan et al. Nature Communications
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
- (2021) Prabhu S. Arunachalam et al. NATURE
- Emerging concepts in the science of vaccine adjuvants
- (2021) Bali Pulendran et al. NATURE REVIEWS DRUG DISCOVERY
- mRNA vaccines manufacturing: Challenges and bottlenecks
- (2021) Sara Sousa Rosa et al. VACCINE
- Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
- (2021) Neil C. Dalvie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Papillomavirus Vaccines
- (2021) Lauri E Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Current and future nanoparticle vaccines for COVID-19
- (2021) Mai N. Vu et al. EBioMedicine
- Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
- (2021) Harry Kleanthous et al. npj Vaccines
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats
- (2020) Kosuke Murakami et al. VACCINE
- Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
- (2020) Eui Ho Kim et al. eLife
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
- (2020) Jinsung Yang et al. Nature Communications
- Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
- (2020) Antoni G. Wrobel et al. Nature Communications
- Addressing the Cold Reality of mRNA Vaccine Stability
- (2020) Daan J.A. Crommelin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
- (2020) Tsun-Yung Kuo et al. Scientific Reports
- Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
- (2019) Shuting Shi et al. VACCINE
- Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
- (2019) Sanjeev Agarwal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination
- (2018) Theodora Ulli Jordanka Bruun et al. ACS Nano
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
- (2018) Harm HogenEsch et al. npj Vaccines
- AS03- and MF59-Adjuvanted Influenza Vaccines in Children
- (2017) Amanda L. Wilkins et al. Frontiers in Immunology
- Accurate design of megadalton-scale two-component icosahedral protein complexes
- (2016) J. B. Bale et al. SCIENCE
- Formulation and stabilization of recombinant protein based virus-like particle vaccines
- (2015) Nishant K. Jain et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age
- (2015) Julia M. Janssen et al. VACCINE
- Methods for Obtaining and Determination of Squalene from Natural Sources
- (2015) Ovidiu Popa et al. Biomed Research International
- Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
- (2015) Farhat Khan et al. PLoS One
- Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
- (2014) Ozan S. Kumru et al. BIOLOGICALS
- The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
- (2013) Samuele Calabro et al. VACCINE
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- Preformulation Characterization of an Aluminum Salt-Adjuvanted Trivalent Recombinant Protein-Based Vaccine Candidate Against Streptococcus Pneumoniae
- (2012) Vidyashankara Iyer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Understanding protein adsorption phenomena at solid surfaces
- (2011) Michael Rabe et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Structural damages in adsorbed vaccines affected by freezing
- (2011) Wiesław Kurzątkowski et al. BIOLOGICALS
- MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
- (2010) Hana El Sahly Expert Review of Vaccines
- Vaccines with Aluminum-containing Adjuvants: Optimizing Vaccine Efficacy and Thermal Stability
- (2010) Tanya Clapp et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response
- (2008) Bethany Hansen et al. VACCINE
- Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways
- (2007) Bruce A. Kerwin JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started